Seek urgent same-day medical attention if you develop: Widespread rash covering large areas of the body Blistering, peeling, or ulceration of the skin Rash involving the mucous membranes (mouth, eyes, genitals) Skin changes accompanied by fever, joint pain, or malaise Contact your healthcare provider within 24-48 hours if you notice: Persistent rash lasting more than a few days Injection site reactions that worsen rather than improve Signs of infection at injection sites (increasing warmth, pus, red streaking) Severe itching that interferes with daily activities or sleep Your physician may recommend temporarily holding Zepbound doses, prescribing symptomatic treatment, or conducting further evaluation to determine the cause of skin changes
Semaglutide Appeared Stronger Than Some Related Drugs Results in the same reports suggested that semaglutide may have had a stronger association with mental-health improvement than certain related medications in the GLP-1 class
Your GP may monitor: Weight and body-composition trends Appetite and eating behaviours Side effects and tolerance Energy levels and hydration Blood-sugar markers, where relevant Follow-up appointments allow your doctor to adjust treatment early if issues arise and to confirm whether the new medication is meeting expectations
Bilingual care Our team speaks English, Spanish, and Polish
An intensive drug regimen that includes an anti-TNF agent is used at the beginning of therapy and subsequently de-escalated when remission is attained
The picture has tightened